- Home
- ELDN vs LCNB Comparison
ELDN vs LCNB Comparison
Compare ELDN & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- LCNB
- Stock Information
- Founded
- ELDN 2004
- LCNB 1877
- Country
- ELDN United States
- LCNB United States
- Employees
- ELDN N/A
- LCNB N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- LCNB Major Banks
- Sector
- ELDN Health Care
- LCNB Finance
- Exchange
- ELDN Nasdaq
- LCNB Nasdaq
- Market Cap
- ELDN 202.4M
- LCNB 205.5M
- IPO Year
- ELDN N/A
- LCNB N/A
- Fundamental
- Price
- ELDN $2.73
- LCNB $14.62
- Analyst Decision
- ELDN Strong Buy
- LCNB
- Analyst Count
- ELDN 2
- LCNB 0
- Target Price
- ELDN $12.50
- LCNB N/A
- AVG Volume (30 Days)
- ELDN 998.5K
- LCNB 22.9K
- Earning Date
- ELDN 11-11-2025
- LCNB 10-20-2025
- Dividend Yield
- ELDN N/A
- LCNB 6.03%
- EPS Growth
- ELDN N/A
- LCNB 186.06
- EPS
- ELDN 0.21
- LCNB 1.49
- Revenue
- ELDN N/A
- LCNB $86,864,000.00
- Revenue This Year
- ELDN N/A
- LCNB $0.86
- Revenue Next Year
- ELDN N/A
- LCNB $5.93
- P/E Ratio
- ELDN $12.80
- LCNB $9.79
- Revenue Growth
- ELDN N/A
- LCNB 22.73
- 52 Week Low
- ELDN $2.32
- LCNB $13.34
- 52 Week High
- ELDN $5.54
- LCNB $17.92
- Technical
- Relative Strength Index (RSI)
- ELDN 54.22
- LCNB 37.77
- Support Level
- ELDN $2.48
- LCNB $14.55
- Resistance Level
- ELDN $2.71
- LCNB $15.03
- Average True Range (ATR)
- ELDN 0.17
- LCNB 0.37
- MACD
- ELDN 0.04
- LCNB -0.12
- Stochastic Oscillator
- ELDN 60.95
- LCNB 12.50
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.